The LAM Australasia Research Alliance (LARA) is dedicated to improving the health prospects of women with LAM in Australia, New Zealand and throughout the region. A disease that affects only women, LAM is rare and often devastating.
Major Donors
Macquarie Group Foundation
Henry H. Roth Charitable Foundation
Hollick Wines
Acknowledgements
LARA thanks the professionals who work pro bono for this not-for-profit organisation. We highly recommend the services of:
Ben Higham, Webhead
Karen Riethmuller, KGR Design
Allan Hughan, Accountant
Peter Kelso, Bartier Perry Lawyers
Contact Us
LAM Australasia Research Alliance
Nevena 0419 185 491
Janet 0411 816 444
PO Box 636 Bondi Junction NSW 1355
Australia
Research
|
Researchers at the University of Cincinnati and Cincinnati Children's Hospital Medical Center have established that a particular blood test can successfully identify lymphangioleiomyomatosis (LAM).
|
|
This project aims to determine whether LAM cells are capable of growing under conditions that favour the generation of self-renewing cancer stem cell-like cells.
|
|
Author: Joel Moss MD PhD Deputy Chief, Translational Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health. Coauthor: John A Kelly MB BCh MD Assistant Professor of Medicine and Micro-Immunology, Dartmouth Medical School
|
|
Terasaki Y, Yahiro K, Pacheco-Rodriguez G, Steagall WK, Stylianou MP, Evans JF, Walker AM, Moss J. Translational Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States.
|
|
Researchers at the Malaghan Institute for Medical Research in Wellington New Zealand have embarked on a one year pilot program studying LAM cells...
|
|
Dr Deborah Yates, Department of Thoracic Medicine, St Vincent's Hospital, Sydney. In 2008 we started enrolling women with LAM for the Doxycycline in LAM trial...
|
|
During a six month visit by Dr Lyn M Moir to Dr Vera Krymskaya’s laboratory, University of Pennsylvania, Philadelphia, PA, USA...
|